Adenosine: Clinical Trials

17 trials of Adenosine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 3 terminated, 1 recruiting, 1 unknown. 17 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 317Completed 11, Terminated 3, Recruiting 1, Unknown 1, Withdrawn 1
Phase 22Completed 2

Follow Adenosine: new trials by email Literature Review of Adenosine trials Research Report on Adenosine

Trials (filtered) newest first · largest first

All 17 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Adenosine as Compared to Verapamil in Paroxysmal Supraventricular Tachycardia (pSVT) Patients
Adenosine, Verapamil Injection - Supraventricular Tachycardia (SVtach)
Phase 3RecruitingRashid Latif Medical College2102024-10-282024-12-13
Adenosine's Effect on STunning Resolution in Acute Myocardial Infarction
Adenosine - Myocardial Ischemia
Phase 3WithdrawnVastra Gotaland Region2023-01-012024-05-17
A Trial to Compare American Heart Association (AHA) and Simple (SIM)Method to Give Adenosine to Treat Supra-ventricular Tachycardia (SVT)
Adenosine - Supra-ventricular Tachycardia
Phase 3CompletedUniversity of Pretoria302018-04-012021-06-25
Regadenoson and Adenosine
Regadenoson central -central, Regadenoson peripheral - peripheral, Regadenoson central - peripheral - Coronary Artery Disease
Phase 3CompletedLokien van Nunen1002013-01-012013-11-13
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
Apadenoson SPECT-MPI, Adenosine SPECT-MPI - Coronary Artery Disease
Phase 3TerminatedForest Laboratories1972011-08-012012-05-01
Comprehensive Evaluation of Ischemic Heart Disease Using MRI
Gadolinium, Adenosine - Heart Disease, Ischemic, Atherosclerosis, Coronary
Phase 2 / Phase 3CompletedNorthwestern University402010-06-012014-09-26
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
Apadenoson SPECT-MPI, Adenosine SPECT-MPI - Coronary Artery Disease
Phase 3TerminatedForest Laboratories8632009-11-012012-05-01
Intracoronary Adenosine Administration to Prevent Periprocedural Myonecrosis in Elective Coronary Angioplasty
Adenosine, Placebo - Coronary Angioplasty
Phase 3CompletedAzienda Ospedaliero Universitaria Maggiore della Carita2602009-11-012011-11-08
Coronary Artery Vasculopathy in Pediatric Heart Transplant Patients
Adenosine - Orthotopic Heart Transplant
Phase 3CompletedBryan Goldstein222008-11-012017-09-26
Myocardial Protection With Adenosine During Primary Percutaneous Coronary Intervention in Pts With STEMI
Adenosine - Acute Myocardial Infarction
Phase 3CompletedDavid Garcia-Dorado2012008-10-012013-02-18
Clopidogrel Versus Adenosin in Non Urgent Percutaneous Coronary Intervention (PCI)
Adenosin, placebo, Clopidogrel - Stable Angina, Percutaneous Coronary Intervention
Phase 3UnknownUniversity of Roma La Sapienza602008-09-012009-05-06
THE REOPEN-AMI STUDY - Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction
adenosine, nitroprusside, placebo - Myocardial Infarction
Phase 2 / Phase 3CompletedCatholic University of the Sacred Heart2402008-01-012012-03-27
Prophylactic Intra-coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis
Adenosine - Coronary Artery Stenosis, Coronary Artery Disease
Phase 3TerminatedOttawa Heart Institute Research Corporation2002007-08-012012-08-29
Efficacy and Safety Study of Binodenoson in Assessing Cardiac Ischemia
binodenoson, adenosine - Coronary Artery Disease
Phase 3CompletedPfizer5782005-10-012012-06-01
ADVANCE MPI 2: Study of Regadenoson Versus Adenoscan® in Patients Undergoing Myocardial Perfusion Imaging (MPI)
Regadenoson, Adenosine - Coronary Artery Disease
Phase 3CompletedGilead Sciences7872004-04-012009-11-26
Efficacy and Safety Study of Binodenoson in Assessing Cardiac Ischemia
binodenoson, adenosine - Coronary Artery Disease
Phase 3CompletedPfizer4192004-02-012012-06-01
ADVANCE MPI 1: Study of Regadenoson Versus Adenoscan® in Patients Undergoing Myocardial Perfusion Imaging (MPI)
Regadenoson, Adenosine - Coronary Artery Disease
Phase 3CompletedGilead Sciences12312003-10-012009-11-26

Conditions studied

Coronary Artery Disease (9)  ·  Myocardial Ischemia (4)  ·  Angina Pectoris (2)  ·  Ischemia (2)  ·  Angina, Stable (1)  ·  Coronary Stenosis (1)  ·  Myocardial Infarction (1)  ·  Tachycardia (1)  ·  Tachycardia, Supraventricular (1)

Sponsors

Forest Laboratories (2)  ·  Gilead Sciences (2)  ·  Pfizer (2)  ·  Azienda Ospedaliero Universitaria Maggiore della Carita (1)  ·  Bryan Goldstein (1)  ·  Catholic University of the Sacred Heart (1)  ·  David Garcia-Dorado (1)  ·  Lokien van Nunen (1)  ·  Northwestern University (1)  ·  Ottawa Heart Institute Research Corporation (1)  ·  Rashid Latif Medical College (1)  ·  University of Pretoria (1)  ·  University of Roma La Sapienza (1)  ·  Vastra Gotaland Region (1)

Countries

United States (6)  ·  Italy (3)  ·  Brazil (2)  ·  Netherlands (2)  ·  Argentina (1)  ·  Belgium (1)  ·  Canada (1)  ·  Pakistan (1)  ·  South Africa (1)  ·  Spain (1)

Top investigators

David B Bharucha, MD, PhD, FACC (2)  ·  Robert L. Rolleri, Pharm.D. (2)  ·  Bryan Goldstein, MD (1)  ·  Filippo Crea, MD (1)  ·  Giampaolo Niccoli, MD, PhD (1)  ·  Giuseppe De Luca, MD (1)  ·  Hafiz Abdul Manan Shahid, FCPS (1)  ·  James C Carr, MD (1)  ·  Lokien X van Nunen, MD (1)  ·  Marino Labinaz, MD FRCP (1)  ·  Nico H.J. Pijls, MD, PhD (1)

Results publications

PMID 17826318, PMID 22000773, PMID 25136887, PMID 25449504, PMID 9426034

NIH funding

2009 (1)